- Director, Technology Dependent Clinic, UH Rainbow Babies and Children's Hospital
- Medical Director, Respiratory Therapy, UH Rainbow Babies and Children's Hospital
- Clinical Instructor, CWRU School of Medicine
Jeffrey Lobas, MD has been a specialist and clinical educator in pediatric pulmonary (lung) disease in the Division of Pediatric Pulmonology, Allergy, Immunology and Sleep Medicine at University Hospitals Rainbow Babies & Children’s Hospital since 2019. He sees patients at UH Rainbow Babies & Children’s main campus, UH Landerbrook Health Center, and UH Solon Health Center.
Dr. Lobas’s is the Ventilator Clinical Director and is a lecturer in the fellowship's core lecture series.
Dr. Lobas is board certified in pediatric pulmonology and pediatrics. His academic and research interests include the care of children with special health care needs, technology dependent and complex care areas.
Dr. Lobas’ previous service includes tenures at Loma Linda Children’s Hospital in California, The University of Minnesota, the University of Iowa, the Iowa Department of Public Health, and as the CEO/CMO of the Children’s Hospitals of California Health Alliance and the Institute for Transforming Healthcare.
- Pediatric Pulmonology - American Board of Pediatrics
- Pediatrics - American Board of Pediatrics
University Of St Thomas (2000 - 2005)
Fellowship | Pediatric Pulmonology
Pediatric Pulmonology - University Of Wisconsin Hospital And Clinics (1983 - 1986)
Fellowship | Pediatric Critical Care Medicine
Pediatric Critical Care Medicine - University Of Wisconsin Hospital And Clinics (1983 - 1986)
Residency | Pediatrics/Chief Resident
Pediatrics/Chief Resident - Medical College Of Ohio Hospital (1982 - 1983)
Residency | Internal Medicine/Pediatrics
Internal Medicine/Pediatrics - Medical College Of Ohio Hospital (1981 - 1982)
Internship | Internal Medicine
Internal Medicine - Medical College Of Ohio Hospital (1980 - 1981)
Internship | Pediatrics
Pediatrics - OHSU Doernbecher Children's Hospital (1979 - 1980)
The Ohio State University (1973 - 1974)
Medical College Of Ohio (1979)
Purdue University (1972)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Jeffrey Lobas did not disclose any Outside Relationships with Industry.